ALK-Abelló (Germany)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Germany), Germany, covering academic research published from 2001 to 2024. Read More.

Open Access Percentage

57%

Total
Publications

Total Open
Publications

Total
Citations

3.4K

Open Access
Percentage

57%

Total
Publications

Total Open
Publications

Total
Citations

3.4K

Wikipedia

Website

download

Breakdown

Publisher Open

22%

Both

17%

Other Platform Open

18%

Closed

43%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 32%

Hybrid 22%

No Guarantees 46%

Other Platform Open

Domain 45%

Institution 30%

Other Internet 30%

Preprint 12%

Public 3%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	15
Europe PMC	Domain	8
DOI	Other Internet	8
Unknown Repository	Other Internet	4
Utrecht University - Utrecht University Repository	Institution	2
King's College London - Research Portal	Institution	2
bioRxiv	Preprint	2
Bielefeld University - PUB – Publications at Bielefeld University	Institution	2
Uppsala University - Uppsala University Publications	Institution	1
Universitätsbibliothek der Freien Universität Berlin - Refubium	Institution	1

1 / 3

Data updated 7 April 2025